Acupuncture for mild cognitive impairment

Acupuncture for the mild cognitive impairment: randomized, patient-assessor blinded, controlled pilot clinical trial

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0001938

Enrollment

Registered

2016-06-03

Start date

2016-01-05

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device : A study that compares treatment efficacy of acupuncture VS sham acupuncture in the treatment of mild cognitive impairment. Treatment regimen: 2 times/week for 12 weeks

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. 50 Years and older 2. Patients who meet the Peterson diagnostic criteria of MCI with memory problems at least for 3 months 3. clinical dementia rating score: 0.5 4. global deterioration scale score: 2-3 5. Hachinski ischemic score < 4 6. at least 6 years of education 7. agreed with written informed consent

Exclusion criteria

Exclusion criteria: 1. Dementia by Diagnostic and Statistical Manual of Mental Disorders-IV 2. History of cognitive impairment due to any other cause (head trauma or brain injury, etc.) 3. History of cerebral hemorrhage or infarction 4. Parkinson’s disease, normal pressure hydrocephalus, brain tumor, cerebrovascular disease 5. psychiatric illnesses such as schizophrenia, delusional disorder, bipolar disorder 6. severe medical disease (diabetic complications, cardiovascular, hepatic, or renal disorder, malignancy) 7. anemia, hypothyroidism, vitamin deficiencies 8. any history of drug or alcohol dependence during the past 6 months 9. currently taking any medication for cognitive function 10. received any treatment for MCI within 2 weeks 11. illiterate 12. Patients who were involved in other clinical trials within 4 weeks 13. known hypersensitivity reaction after acupuncture treatment or inability to cooperate with acupuncture procedure 14. pregnant, expecting pregnant or nursing women 15. difficult for adaptation that treatment, visit, answer the questionnaire 16. Those who are not willing to comply with this study protocol

Design outcomes

Secondary

Measure	Time frame
Montreal Cognitive Assessment-K;Seoul Neuropsychological Screening Battery ;Patient Global Impression of Change ;Adverse events	—

Primary

Measure	Time frame
Alzheimer's Disease Assessment Scale cognitive subscale	—

Countries

Korea, Republic of

Contacts

Public ContactJeong-hyo Cho

Daejeon Korean Medicine Hospital of Daejeon University

choajoa@dju.kr

Outcome results